Cargando…

Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy

This article evaluates the epidemiological evidence for a relationship between vaccination and neurological disease, specifically multiple sclerosis, Guillain–Barré syndrome and narcolepsy. The statistical methods used to test vaccine safety hypotheses are described and the merits of different study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stowe, Julia, Andrews, Nick, Miller, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224038/ https://www.ncbi.nlm.nih.gov/pubmed/31576507 http://dx.doi.org/10.1007/s40263-019-00670-y

Ejemplares similares

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2019)

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
por: Zheng, Crystal, et al.
Publicado: (2020)

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia
por: Vella, Venanzio, et al.
Publicado: (2021)

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
por: Waheed, Sadia, et al.
Publicado: (2021)

Guillain Barre syndrome as a manifestation of neurological melioidosis
por: Krovvidi, Rajesh, et al.
Publicado: (2013)

Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine()
por: Nevin, Remington L.
Publicado: (2014)

Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination
por: Carranza, Octavio, et al.
Publicado: (2022)

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing
por: Dalakas, Marinos C.
Publicado: (2020)

Prevalence of fatigue in Guillain-Barre syndrome in neurological rehabilitation setting
por: Ranjani, Prajna, et al.
Publicado: (2014)

Could Guillain–Barré syndrome be triggered by COVID‐19 vaccination?
por: Aldeeb, Maya, et al.
Publicado: (2022)

A rare neurological complication of typhoid fever: Guillain-Barre’ syndrome
por: Kapoor, Kapil, et al.
Publicado: (2014)

SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)

Muscle-strengthening Exercise Epidemiology: a New Frontier in Chronic Disease Prevention
por: Bennie, Jason A., et al.
Publicado: (2020)

Cytomegalovirus and Epstein–Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development
por: Maple, Peter A. C.
Publicado: (2020)

Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Assessing the Safety of COVID-19 Vaccines: A Primer
por: Petousis-Harris, Helen
Publicado: (2020)

Strategies to Reduce Errors Associated with 2-Component Vaccines
por: Samad, Farzana, et al.
Publicado: (2020)

Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England
por: Winstone, Anne Marie, et al.
Publicado: (2014)

Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines
por: Benn, Christine Stabell, et al.
Publicado: (2023)

Common Neurologic Features of Lyme Disease That May Present to a Rheumatologist
por: Govil, Swati, et al.
Publicado: (2023)

Neurological Consequences of COVID-19: A Curious Case of Delayed Onset Guillain-Barre
por: Devarakonda, Aditya K, et al.
Publicado: (2022)

“Guillain-Barré Syndrome After COVID-19 Vaccination in an Adolescent” [Pediatric Neurology, Volume 126, January 2022, Pages 9-10]
por: Malamud, Emily, et al.
Publicado: (2022)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Vaccination of chickens against coccidiosis ameliorates drug resistance in commercial poultry production
por: Chapman, H. David, et al.
Publicado: (2014)

Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
por: Jit, Mark, et al.
Publicado: (2016)

Deceleration Training in Team Sports: Another Potential ‘Vaccine’ for Sports-Related Injury?
por: McBurnie, Alistair J., et al.
Publicado: (2021)

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
por: Shrestha, Sunil, et al.
Publicado: (2021)

Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020
por: Martinez-Cabriales, Sylvia A., et al.
Publicado: (2021)

Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
por: Sagili Anthony, Deva Priya, et al.
Publicado: (2021)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

Neurological relapse of acute lymphoblastic leukemia mimicking COVID-19 associated Guillain-Barré Syndrome
por: Oumerzouk, J., et al.
Publicado: (2022)

Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome
por: Ling, Ling, et al.
Publicado: (2021)

Internal and External Barriers to Bladder Management in Persons with Neurologic Disease Performing Intermittent Catheterization
por: Herbert, Amber S., et al.
Publicado: (2023)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
por: Ference, Brian A., et al.
Publicado: (2017)

Guillain-Barré syndrome and influenza vaccines: current evidence
por: Fadrique, Rosario Sanz, et al.
Publicado: (2019)

Influenza Vaccination and Guillain–Barré Syndrome: Reality or Fear
por: Babazadeh, Arefeh, et al.
Publicado: (2019)

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Shao, Shih-Chieh, et al.
Publicado: (2021)

Guillain-Barré syndrome after COVID-19 vaccination
por: McKean, Norma, et al.
Publicado: (2021)

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pcdmkqjjda4n50iq7g1ahnedvr